Neurosense Therapeutics Ltd.盘中异动早盘快速下挫5.26%

市场透视2025-12-30

北京时间2025年12月30日23时28分，Neurosense Therapeutics Ltd.（NRSN.us）股票出现异动，股价大幅下跌5.26%。截至发稿，该股报0.720美元/股，成交量5.755万股，换手率0.19%，振幅3.55%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.21百万美元，每股收益-0.55美元，毛利-22000.00美元，市盈率-2.01倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2595773919?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-30 23:28","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2595773919","market":"us","top_or_hot":-1,"title":"Neurosense Therapeutics Ltd.盘中异动 早盘快速下挫5.26%","media":"市场透视","content":"<div>\n<p>北京时间2025年12月30日23时28分，Neurosense Therapeutics Ltd.（NRSN.us）股票出现异动，股价大幅下跌5.26%。截至发稿，该股报0.720美元/股，成交量5.755万股，换手率0.19%，振幅3.55%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.21百万美元，每股收益-0.55美元，毛利-22000.00美元，市盈率-2.01倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230232835a6e1e64b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Neurosense Therapeutics Ltd.盘中异动 早盘快速下挫5.26%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNeurosense Therapeutics Ltd.盘中异动 早盘快速下挫5.26%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-30 23:28 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230232835a6e1e64b&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年12月30日23时28分，Neurosense Therapeutics Ltd.（NRSN.us）股票出现异动，股价大幅下跌5.26%。截至发稿，该股报0.720美元/股，成交量5.755万股，换手率0.19%，振幅3.55%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.21百万美元，每股收益-0.55美元，毛利-22000.00美元，市盈率-2.01倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230232835a6e1e64b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230232835a6e1e64b&s=b","article_id":"2595773919","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230232835a6e1e64b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2595773919","pubTimestamp":1767108514,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年12月30日23时28分，Neurosense Therapeutics Ltd.股票出现异动，股价大幅下跌5.26%。截至发稿，该股报0.720美元/股，成交量5.755万股，换手率0.19%，振幅3.55%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.79%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4539":"次新股","BK4139":"生物科技","BK4007":"制药","NRSN":"Neurosense Therapeutics Ltd","LENZ":"Therapeutics"},"translate_title":"Neurosense Therapeutics Ltd. Intraday changes fell 5.26% quickly in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1.5,"NRSN":1.5},"content_text":"北京时间2025年12月30日23时28分，Neurosense Therapeutics Ltd.（NRSN.us）股票出现异动，股价大幅下跌5.26%。截至发稿，该股报0.720美元/股，成交量5.755万股，换手率0.19%，振幅3.55%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.21百万美元，每股收益-0.55美元，毛利-22000.00美元，市盈率-2.01倍。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.79%。其相关个股中，Dermata Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 (To Pur Com)、Sellas Life Sciences Group, Inc.涨幅较大，Dermata Therapeutics, Inc.、Gri Bio, Inc.、Theriva Biologics, Inc.较为活跃，换手率分别为1803.97%、624.23%、38.79%，振幅较大的相关个股有Cdt Equity Inc C/Wts 22/09/2028(To Pur Com)、Briacell Therapeutics Corp C/Wts 26/02/2026(To Pur Com)、Protagenic Therapeutics Inc C/Wts 26/04/2026 (To Pur Com)，振幅分别为40.00%、37.47%、37.42%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症（ALS），阿尔茨海默病和帕金森病等。公司的候选产品PrimeC是一种新型的缓释口服制剂，由FDA批准的两种非专利药物环丙沙星和塞来昔布按特定比例组合而成的固定剂量组合。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2595773919","isCrawlerRequest":true}

Neurosense Therapeutics Ltd.盘中异动 早盘快速下挫5.26%

精彩评论

Neurosense Therapeutics Ltd.盘中异动早盘快速下挫5.26%